Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging(in press) DOI 10.1007/s00259-025-07330-y, PubMed 40397137
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB(2025) Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy Mol Cancer Ther(in press) DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114
Song L, Kostas M, Laerdahl JK, Skálová M, Janská T, Juzeniene A, Ræstad S, Krivokapic A, Kalantzopoulos GN, Soltes J, Vlk M, Kozempel J, Hassfjell S, Wesche J(2025) Preparation and Characterization of an Engineered FGF1 Conjugated to 161Tb for Targeting of FGFRs ACS Omega, 10(6), 5730-5743 DOI 10.1021/acsomega.4c09179, PubMed 39989790
